Preparation method of LDHs (layered double hydroxides) and application of LDHs in catalytic degradation of antibiotics
Co/Fe-LDH composite materials were prepared by co-precipitation method, and free radicals were activated in combination with the PMS system, which solved the problems of low antibiotic degradation efficiency and insufficient catalyst stability in the prior art, and achieved efficient degradation of antibiotics in water and stability of catalysts. and reusability.
Patent Information
- Application Number
- CN202411390264.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-08
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art has difficulty in activating O-O bonds in persulfates in removing antibiotic residues in water, resulting in low catalytic degradation efficiency and insufficient stability and reusability of the catalyst.
Co-precipitation method is used to prepare layered bimetallic hydroxides (LDHs), such as Co/Fe-LDH. By adjusting the metal molar ratio and pH value, a Co/Fe-LDH composite material with high catalytic activity and stability is formed, combined with The PMS system activates free radicals and promotes the degradation of antibiotics.
It has achieved efficient degradation of a variety of antibiotics (such as levofloxacin, tetracycline hydrochloride, and sulfamethiadiazole), which has improved the stability and reusability of the catalyst, and has significantly improved the degradation efficiency and application value.
Smart Images

Figure CN119034741A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of sewage treatment, and in particular to a method for preparing LDHs and application thereof in catalytic degradation of antibiotics. Background Art
[0002] With the rapid development of medicine, antibiotics are widely used in animals and humans to prevent bacterial infections. However, antibiotics cannot be completely absorbed by animals and humans. More than 75% of antibiotics still enter water bodies through the digestive system in the form of urine and feces. Many antibiotics have been detected in natural water bodies discharged from sewage treatment plants, aquaculture farms, livestock and poultry farms, etc. Levofloxacin (LEV) is a fluoroquinolone antibiotic. The metabolites of quinolone antibiotics have the same or even toxic properties as the parent antibiotics. They are often detected in surface water, groundwater and tap water, and pose potential hazards to aquatic plants and animals. Sulfamethizole (SMX) is a sulfonamide antibiotic. Most of the drugs are excreted in the form of prototypes or metabolites. After entering the water body, they will form "pseudo-persistent" pollutants, which will bring a series of environmental risks. Tetracycline hydrochloride (TC-HCl) is a tetracycline antibiotic. However, due to its low absorption rate, a large amount of TC-HCl enters the environment directly in the form of stock solution with excrement. The process of decomposition by itself without external interference is very slow, causing great damage to the environment and may even lead to more serious consequences. Therefore, taking effective measures to remove antibiotics in water has become an environmental problem that humans need to solve urgently.
[0003] So far, many technologies have been developed to remove these residual antibiotics (e.g., advanced oxidation processes (AOPs), adsorption, biochemical treatment, etc.), among which AOPs (PMS, Fenton-like system) based on the activation of sulfate radicals of peroxymonosulfate have broad development prospects in the removal of antibiotics due to their strong oxygen quality, durability, low cost and convenient operation. However, how to quickly and effectively activate the OO bond in PMS (persulfate) to form sulfate is the key to its function. Ultraviolet (UV), heat treatment and ultrasonic treatment are usually used, but in recent years, the effect of transition metal catalysts has been more obvious, and they are often designed in the form of sulfide, hydroxide and oxide catalysts for activation. Summary of the invention
[0004] The technical problem to be solved by the present invention is to overcome the deficiencies in the prior art and provide a method for preparing LDHs and an application thereof in catalytic degradation of antibiotics.
[0005] The present invention is achieved through the following technical solutions:
[0006] A method for preparing LDHs comprises the following steps:
[0007] S1. Mixing the divalent metal and the trivalent metal according to the metal molar ratio of 2:1-4:1, taking the same volume of the divalent metal solution and the trivalent metal solution to obtain a mixed solution;
[0008] S2. NaOH solution was added dropwise to the mixed solution, and the pH value was adjusted to alkaline and then allowed to stand;
[0009] S3. Filter and wash with deionized water, and then dry to obtain a layered double metal hydroxide material.
[0010] According to the above technical solution, preferably, in step S1, the divalent metal is Cu 2+ Mg 2+ or Co 2+ Any one of the above, the divalent metal solution is any one of Cu(NO3)2·3H2O, Mg(NO3)2·6H2O or Co(NO3)2·6H2O solution, and the layered double hydroxide materials prepared therefrom are Cu / Fe-LDH, Mg / Fe-LDH, and Co / Fe-LDH respectively.
[0011] According to the above technical solution, preferably, in step S1, the trivalent metal is Fe 3+ , the trivalent metal solution is Fe(NO3)3·9H2O solution.
[0012] According to the above technical solution, preferably, in step S1, a divalent metal and a trivalent metal are mixed at a metal molar ratio of 2:1-4:1, and 100 mL of a divalent metal solution and a trivalent metal solution are taken to obtain a mixed solution, wherein the total concentration of divalent metal and trivalent metal ions in the mixed solution is 0.5 mol / L.
[0013] According to the above technical solution, preferably, in step S1, the divalent metal is Co 2+ , the divalent metal solution is Co(NO3)2·6H2O solution.
[0014] According to the above technical solution, preferably, in step S2, NaOH solution is added dropwise to the mixed solution, the pH value is adjusted to 13, and then the solution is allowed to stand at room temperature for 24 hours.
[0015] The present application also discloses an application of LDHs in catalytic degradation of antibiotics. Based on the preparation method of the above-mentioned LDHs, the Cu / Fe-LDH, Mg / Fe-LDH, and Co / Fe-LDH catalyze the degradation of levofloxacin, tetracycline hydrochloride, and sulfamethoxazole in a PMS system.
[0016] According to the above technical scheme, preferably, based on the condition that the initial mass concentration of levofloxacin, tetracycline hydrochloride and sulfamethoxazole is 30 mg / L, the dosage of the Co / Fe-LDH is 0.01 g, the dosage of the PMS is 0.01 g, and the initial pH value is 7, the catalytic degradation of levofloxacin, tetracycline hydrochloride and sulfamethoxazole is achieved.
[0017] According to the above technical solution, preferably, the Co / Fe-LDH can be repeatedly used in the PMS system to catalyze the degradation of levofloxacin, tetracycline hydrochloride, and sulfamethizole, or can be used simultaneously to catalyze the degradation of levofloxacin, tetracycline hydrochloride, and sulfamethizole.
[0018] The beneficial effects of the present invention are:
[0019] The present invention adopts a coprecipitation method to prepare LDHs of different divalent metals and trivalent metals. The Co / Fe-LDH composite material prepared after optimization has a layered structure of LDH that provides a large number of active sites. The synergistic effect of Co and Fe in the LDH structure not only enhances the catalytic activity of LDH, but also may lead to the exposure of more active sites. These sites can effectively interact with PMS and promote the generation of effective free radicals, thereby having a high ability to degrade multiple antibiotics. In addition, the stability and reusability of the Co / Fe-LDH composite material also demonstrate its potential in practical applications, and has a high application and promotion value. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 It is a schematic diagram of the effect of divalent metal types on antibiotic degradation performance in the present invention.
[0021] Figure 2 It is a schematic diagram of the effect of different metal ratios on the antibiotic degradation efficiency in the present invention.
[0022] Figure 3 1 is the XRD diagram of Co / Fe-LDH before and after degradation in the present invention.
[0023] Figure 4 It is the FTIR graph of Co / Fe-LDH before and after degradation in the present invention.
[0024] Figure 5 It is a schematic diagram of the LEV quenching test results in the present invention.
[0025] Figure 6 It is a schematic diagram of the SMX quenching test results in the present invention.
[0026] Figure 7 It is a schematic diagram of the results of the TC-HCl quenching test in the present invention.
[0027] Figure 8 It is a schematic diagram of the results of Co / Fe-LDH degrading LEV with different initial concentrations in the present invention.
[0028] Fig. 9 It is a schematic diagram of the results of Co / Fe-LDH degrading SMX with different initial concentrations in the present invention.
[0029] Fig.10 It is a schematic diagram of the results of Co / Fe-LDH degrading TC-HCl with different initial concentrations in the present invention.
[0030] Fig.11 It is a schematic diagram of the results of LEV degradation with different Co / Fe-LDH dosages in the present invention.
[0031] Fig.12 It is a schematic diagram of the results of SMX degradation with different Co / Fe-LDH dosages in the present invention.
[0032] Fig.13 It is a schematic diagram of the results of degrading TC-HCl with different Co / Fe-LDH dosages in the present invention.
[0033] Fig.14 It is a schematic diagram of the results of LEV degradation with different PMS dosages in the present invention.
[0034] Fig.15 It is a schematic diagram of the results of SMX degradation with different PMS dosages in the present invention.
[0035] Fig.16 It is a schematic diagram of the results of degrading TC-HCl with different PMS dosages in the present invention.
[0036] Fig.17 It is a schematic diagram of the effect of initial pH on the degradation of LEV in the present invention.
[0037] Fig.18 It is a schematic diagram of the effect of initial pH on the degradation of SMX in the present invention.
[0038] Fig.19 It is a schematic diagram of the effect of initial pH on the degradation of TC-HCl in the present invention.
[0039] Fig. 20 It is a schematic diagram of the LEV cyclic degradation results in the present invention.
[0040] Fig.21 It is a schematic diagram of the cyclic degradation results of SMX in the present invention.
[0041] Fig. 22 It is a schematic diagram of the TC-HCl cyclic degradation results in the present invention.
[0042] Fig.23 It is a schematic diagram of the synergistic degradation results of LEV, SMX and TC-HCl in the present invention. DETAILED DESCRIPTION
[0043] In order to enable those skilled in the art to better understand the technical solution of the present invention, the present invention is further described in detail below in conjunction with the accompanying drawings and the best embodiment. Based on the embodiments in the invention, all other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of the invention.
[0044] Embodiment 1: The present invention comprises the following steps:
[0045] S1. Mix the divalent metal solution and the trivalent metal solution in the same volume according to the metal molar ratio of 2:1-4:1 to obtain a mixed solution. Specifically, the divalent metal in this example is Cu 2+ , the divalent metal solution is Cu(NO3)2·3H2O, and the trivalent metal is Fe 3+ , the trivalent metal solution is Fe(NO3)3·9H2O solution.
[0046] Cu 2+ with Fe 3+ According to the metal molar ratio of 2:1-4:1, 100 mL of Cu(NO3)2·3H2O and Fe(NO3)3·9H2O were mixed to obtain a mixed solution. 2+ , Fe 3+ The total ion concentration is 0.5 mol / L.
[0047] S2. NaOH solution was added dropwise to the mixed solution, the pH value was adjusted to 13, and the solution was allowed to stand at room temperature for 24 h.
[0048] S3. Filter and wash with deionized water, place in an oven at 60°C for drying, and obtain a layered double hydroxide material after drying, which is recorded as Cu / Fe-LDH.
[0049] Embodiment 2: The present invention comprises the following steps:
[0050] S1. Mix the divalent metal solution and the trivalent metal solution in the same volume according to the metal molar ratio of 2:1-4:1 to obtain a mixed solution. Specifically, the divalent metal in this example is Mg 2+, the divalent metal solution is Mg(NO3)2·6H2O, and the trivalent metal is Fe 3+ , the trivalent metal solution is Fe(NO3)3·9H2O solution.
[0051] Mg 2+ with Fe 3+ According to the metal molar ratio of 2:1-4:1, 100 mL of Mg(NO3)2·6H2O and Fe(NO3)3·9H2O were mixed to obtain a mixed solution. 2+ , Fe 3+ The total ion concentration is 0.5 mol / L.
[0052] S2. NaOH solution was added dropwise to the mixed solution, the pH value was adjusted to 13, and the solution was allowed to stand at room temperature for 24 h.
[0053] S3. Filter and wash with deionized water, place in an oven at 60°C for drying, and obtain a layered double hydroxide material after drying, which is recorded as Mg / Fe-LDH.
[0054] Embodiment 3: The present invention comprises the following steps:
[0055] S1. Mix the divalent metal solution and the trivalent metal solution in the same volume according to the metal molar ratio of 2:1-4:1 to obtain a mixed solution. Specifically, the divalent metal in this example is Co 2+ , the divalent metal solution is Co(NO3)2·6H2O, and the trivalent metal is Fe 3+ , the trivalent metal solution is Fe(NO3)3·9H2O solution.
[0056] Co 2+ with Fe 3+ According to the metal molar ratio of 2:1-4:1, 100 mL of Co(NO3)2·6H2O and Fe(NO3)3·9H2O were mixed to obtain a mixed solution. 2+ , Fe 3+ The total ion concentration is 0.5 mol / L.
[0057] S2. NaOH solution was added dropwise to the mixed solution, the pH value was adjusted to 13, and the solution was allowed to stand at room temperature for 24 h.
[0058] S3. Filter and wash with deionized water, place in an oven at 60°C for drying, and obtain a layered double hydroxide material after drying, which is recorded as Co / Fe-LDH.
[0059] Example 4: The present application also discloses an application of LDHs in catalytic degradation of antibiotics. Based on the above-mentioned method for preparing LDHs, the Cu / Fe-LDH, Mg / Fe-LDH, and Co / Fe-LDH catalyze the degradation of levofloxacin (LEV), tetracycline hydrochloride (TC-HCl), and sulfamethoxazole (SMX) in a PMS system.
[0060] Layered double hydroxides (LDHs) have great advantages in effectively activating PMS due to their controllable interlayer spacing, rich variety, and negative charge exchange properties between layers. The general formula of LDHs is [M 1-x 2+ M x 3+ (OH)2] x+ [(A n -) x / n ·mH2O] x -, LDHs are composed of a metal double layer, in which a portion of the divalent metal cations M 2+ (such as Mg 2+ 、Zn 2+ , Cu 2+ and Co 2+ ) The octahedral site coordinated by the hydroxyl group is occupied by a trivalent metal cation M 3+ (such as Cr 3+ 、Al 3+ , Fe 3+ 、Co 3+ 、Ce 3+ and La 3+ ) to obtain a positively charged layer. Among them, Co and Fe have attracted extensive attention in catalytic PMS due to their special chemical properties. 3+ In the process of generating sulfate radicals, Co plays the role of electron transfer. 2+ It participates in the capture and transfer of electrons when activating PMS, enhancing the generation efficiency of sulfate free radicals.
[0061] Levofloxacin (LEV), sulfamethoxazole (SMX), and tetracycline hydrochloride (TC-HCl) were used as target pollutants, and the catalytic activity of the catalyst was evaluated by catalytic activation of PMS reaction. The degradation test was carried out in a 250mL conical flask. After adding 100mL of the target pollutant, 0.01g of the catalyst was added. The adsorption test was first carried out for 60min, and then 0.01g of PMS was added for activation. The whole process was carried out in a shaker (25℃180r / min). During the reaction, 1mL of the solution was collected at time intervals with a syringe and filtered through a 0.22μm microporous filter membrane. The concentrations of LEV, SMX, and TC-HCl in the solution were determined by high performance liquid chromatography. The degradation efficiency (C tThe relationship between the initial concentration and the degradation time is used to obtain the catalytic degradation trend, where C0 is the initial concentration and C t is the concentration at a given time.
[0062] like Figure 1 As shown in the figure, under the same antibiotic concentration (30 mg / L) and pH = 7 conditions, the results showed that the degradation efficiency of Cu / Fe-LDH and Mg / Fe-LDH for the three antibiotics was in the range of 20%-40%, while the degradation efficiency of Co / Fe-LDH reached 80%-98%. This significant difference in efficiency stems from the fact that Co2+ is more active than Cu2+ and Mg2+ in catalyzing persulfate (PMS). The electronic structure of Co2+ interacts with PMS and may generate more free radicals. In addition, the layered structure of LDH provides a large number of active sites, which are more effectively utilized due to the high activity of Co2+, thereby improving the degradation efficiency.
[0063] like Figure 2 As shown in the figure, by changing the metal ratio while keeping the initial concentration and pH conditions unchanged, the effect on the antibiotic degradation efficiency was studied. The results showed that with the increase of the Co2+ ratio, the antibiotic degradation efficiency of Co / Fe-LDH showed an increasing trend, especially when the metal ratio reached 4:1, the degradation efficiency was the highest, because the high ratio of Co2+ not only enhanced the catalytic activity of LDH, but also led to more active sites exposed, which can effectively interact with PMS to generate more catalytic active centers. Therefore, by adjusting the metal ratio, especially increasing the content of Co2+, the degradation efficiency of LDH materials for antibiotics can be significantly improved.
[0064] The XRD spectra of Co / Fe-LDH before and after removing LEV, TC-HCl, and SMX are shown in Figure 2. Figure 3 As shown. Before the reaction, the material has typical reflection peaks at 2θ=11.33°, 22.85°, 33.75°, and 69.03°, corresponding to the crystal planes (003), (006), (012), and (110), which are consistent with the Co / Fe-LDHs standard card (PDF#50-0235), proving that it has good layered structure and crystal integrity. After removing the antibiotics in the PMS system, the main diffraction peaks are still maintained, indicating that the layered structure of LDH remains stable during the reaction, but the intensity of the diffraction peaks is weakened, suggesting that new compounds such as Co(OH)2 and Fe(OH)3 are formed on the surface of the material. This is because the synergistic effect of Co and Fe metal ions in the LDH+PMS system enhances the activation ability of PMS, resulting in the generation of a large number of hydroxyl radicals. The generation of hydroxyl radicals may lead to the reaction of these metal ions with hydroxyl groups, changing the surface and possible part of the internal structure of LDH, and increasing the catalytic active sites.
[0065] Co / Fe-LDH+PMS→·OH+other products
[0066] Co / Fe-LDH-(·OH)+PMS→Co / Fe-LDH-(SO4 2- )+·OH
[0067] Co 2+ +OH·→Co(OH)2
[0068] Fe 3+ +OH·→Fe(OH)3+3H +
[0069] The FTIR spectra of Co / Fe-LDH before and after removing LEV, TC-HCl, and SMX are shown in Figure 2. Figure 4 As shown, 3700-3456cm -1 The HOH stretching vibration peak in the aqueous solution at 1649 cm-1 was enhanced, indicating that more hydroxyl radicals were generated during the activation of PMS. These hydroxyl radicals are generated by the decomposition of PMS and are highly reactive, which can effectively catalyze the degradation of antibiotics. -1 SO4 is produced 2- The stretching vibration peak is mainly due to the fact that more SO4 is produced after LDH activates PMS 2- , which in turn promotes the removal of antibiotics. -1 The absorbance peak at 1380cm is the vibration of adsorbed water. -1 NO3 - The stretching vibration peak of NO3 - Participated in the intercalation of the laminate. In addition, at 1000cm -1 The following bands are composed of metal-oxygen (MO) and metal-hydroxyl (M-OH) lattice vibration peaks, which further confirm the active participation of Co and Fe ions in the catalytic reaction, which promote the decomposition of PMS and the generation of hydroxyl radicals through strong interactions with oxygen and hydroxyl groups.
[0070] In order to determine the role of the main active species in the Co / Fe-LDH / PMS reaction system, a series of quenching experiments were performed by adding various scavengers. Tert-butyl alcohol (TBA), furfuryl alcohol (FFA) and methanol (MeOH) were selected as ·OH, SO4 · -and 1 O2 scavenger. Based on the inhibition efficiency of the scavenger on LEV, SMX, and TC-HCl, the active species that play a major role in degradation in the system can be inferred.
[0071] like Figure 5As shown in the figure, after adding FFA, the degradation rate of LEV dropped from 90% when no scavenger was added to 70%, which indicates that FFA has a great influence on SO4 ·- The removal of SO4 resulted in a decrease in degradation efficiency of about 22%. This significant change indicates that SO4 ·- It plays a leading role in LEV degradation. Further analysis of SO4 · - reaction kinetics, it can be inferred that SO4 ·- By attacking the aromatic ring in the LEV molecule, the complexation reaction is promoted, which may involve the movement of electrons, thereby causing the breakage of the molecular structure.
[0072] like Figure 6 As shown in Figure 2, for SMX, the degradation efficiency decreased by about 10% after adding MeOH, while the degradation efficiency decreased by 20% and 30% after adding FFA and TBA, respectively. ·- and 1 O2 plays a role in the degradation of SMX. In particular, the sulfamide group in the molecular structure of SMX 1 O2 is particularly sensitive. 1 O2 may induce an oxidation reaction on this group, resulting in changes or breakage of the molecular structure. In addition, the degradation efficiency decreased after adding MeOH, indicating that other free radicals (such as ·OH) also play a role in the degradation process, which may involve multiple oxidation pathways or synergistic effects between free radicals.
[0073] like Figure 7 As shown in the TC-HCl experiment, the addition of TBA and FFA resulted in a significant decrease in the degradation efficiency, indicating that ·OH and SO4 ·- It has a significant effect on the degradation of TC-HCl. TC-HCl molecules may contain OH and SO4 ·- The specific functional groups attacked make the oxidation of these two free radicals particularly important in the degradation process of TC-HCl.
[0074] At the same time, in the degradation pathways of the three antibiotics, a small part of LDH-PMS accepted electrons from the electron-rich SMX, resulting in the self-oxidative decomposition of the antibiotics, while the electron-poor PMS was degraded by the surface-bound SO4 ·- In summary, the most important free radical group in the Co / Fe-LDH / PMS reaction is SO4 ·- and OH, secondly 1 The effect of O2 is negligible.
[0075] Example 5: The present application also discloses an application of LDHs in catalytic degradation of antibiotics. Based on the above-mentioned method for preparing LDHs, the Co / Fe-LDH catalytically degrades levofloxacin (LEV), tetracycline hydrochloride (TC-HCl), and sulfamethoxazole (SMX) in a PMS system. Specifically, based on the initial mass concentration of levofloxacin, tetracycline hydrochloride, and sulfamethoxazole being 30 mg / L, the dosage of the Co / Fe-LDH is 0.01 g, the dosage of PMS is 0.01 g, and the initial pH value is 7, catalytic degradation of levofloxacin, tetracycline hydrochloride, and sulfamethoxazole.
[0076] Degradation experiments were carried out under the same reaction conditions as the control experiment to investigate the effects of factors such as pH, initial solution concentration and catalyst dosage on the degradation efficiency of LEV, SMX and TC-HCl.
[0077] like Figure 8-10 As shown in the catalytic degradation experiment of three antibiotics, LEV, SMX and TC-HCl, in the Co / Fe-LDH+PMS system, the degradation efficiency of the catalyst showed a decreasing trend with the increase of initial concentration. For TC-HCl, when its initial concentration increased from 1 mg / L to 75 mg / L, the degradation rate after 5 minutes decreased from 99.9% to 82.5%. This phenomenon is due to the fact that the Co and Fe metal centers can effectively activate persulfate (PMS) to produce SO4 with high oxidation ability. 2- As the initial concentration increases, more and more antibiotic molecules bind to the active center of the catalyst, resulting in the gradual saturation of the binding sites. Since the number of active sites on the catalyst surface that can catalyze reactants is limited, too many antibiotic molecules will reduce the effective contact area between PMS and the catalyst, thereby inhibiting the activation of the catalyst on PMS, resulting in the generation of sulfate radicals (SO4 2- ) decreased, and the degradation efficiency decreased. Combining the experimental results and the characteristics of the Co / Fe-LDH catalyst, it can be inferred that at an initial mass concentration of 30 mg / L, Co / Fe-LDH can provide sufficient active sites to degrade LEV, SMX, and TC-HCl, and can also maintain the efficient activation of PMS, thereby achieving efficient degradation in a short time.
[0078] In the Co / Fe-LDH / PMS system, the dosage of the catalyst is a key factor affecting the degradation efficiency of antibiotics. Under the experimental conditions of fixed PMS dosage of 0.01g, pH value of 7, and LEV, SMX, and TC-HCl concentrations set to 30mg / L, the effect of Co / Fe-LDH dosage on the degradation efficiency of LEV, SMX, and TC-HCl was investigated. Figure 11-13As shown in the figure, as the catalyst increases from 0.01g to 0.08g, the degradation efficiency of LEV, SMX and TC-HCl increases to different degrees. The degradation rate of LEV in 5 minutes increases by 10%, the degradation rate of SMX increases by 15%, and the degradation rate of TC-HCl increases by 5%. The results show that with the increase of catalyst dosage, the degradation rate shows an upward trend. This is because with the increase of catalyst dosage, the activatable active sites in PMS increase, more active free radicals are generated, thereby improving the catalytic activity. However, with the increase of Co / Fe-LDH dosage, the degradation efficiency of TC-HCl does not increase much, because although a large number of free radicals are generated during catalyst activation, they cannot contact TC-HCl in time, resulting in self-quenching or inactivation. Therefore, under the conditions of initial concentration of 30mg / L and pH=7, the optimal dosage (0.01g) was selected for the next experimental operation.
[0079] In the catalytic degradation experiments of three antibiotics, LEV, SMX, and TC-HCl, the dosage of persulfate (PMS) significantly affects the degradation efficiency. Under the experimental conditions of fixed material dosage of 0.01g, pH value of 7, and LEV, SMX, and TC-HCl concentrations set to 30mg / L, the effect of PMS dosage on the degradation efficiency of LEV, SMX, and TC-HCl was investigated by changing the dosage of PMS. Figure 14-16 As shown in Figure 2, the removal rates of LEV and TC-HCl did not change significantly after the increase in PMS dosage, while the removal rate of SMX continued to increase. This difference may be due to the excessive amount of PMS causing it to react with the already formed SO4 · - and HO- react to form persulfate radicals (SO5 ·- ), this free radical is compared with SO4 ·- and HO - Therefore, for LEV and TC-HCl, excess PMS did not lead to an increase in degradation efficiency because SO5 ·- The oxidative capacity of SMX is not enough to further improve the degradation of these two compounds. For SMX, although the excess PMS forms a relatively weak oxidant, it still helps its degradation. This is because the molecular structure or reaction pathway of SMX makes it oxidative to SO5 · - is more sensitive. Therefore, under the conditions of initial concentration of 30 mg / L, pH=7, and material dosage of 0.01 g, the optimal dosage of PMS 0.01 g was selected for the experiment.
[0080] Solution pH is a key factor affecting the generation of free radicals in the LDH / PMS system. Therefore, we studied the effect of initial pH on the degradation efficiency of LEV, SMX, and TC-HCl in the Co / Fe-LDH / PMS system. Figure 17-19As shown, for LEV, the degradation effect of Co / Fe-LDH / PMS on it remains at about 95% at pH = 5, 7, and 9, indicating that within this pH range, the Co / Fe-LDH catalyst can stably activate PMS and generate sufficient active free radicals to degrade LEV. However, the degradation effect is significantly reduced under strong acid and strong base conditions (pH = 3, 11), indicating that in an acidic environment, the layered structure of LDH may be destroyed due to excessive protonation, which reduces its ability to activate PMS. Under alkaline conditions, excessive OH- ions may compete with PMS and the generated free radicals, resulting in a decrease in the effectiveness of the active center. For SMX, it has a high removal effect of 95% under neutral conditions, but the degradation effect is significantly reduced under weak acid and weak base and strong acid and strong base conditions. This is because the activity of Co / Fe-LDH / PMS is affected under different pH conditions, and the change in pH value affects SO4 - and HO - For TC-HCl, the degradation efficiency first increases and then decreases under acidic conditions because in a slightly acidic environment (pH = 5), the free radicals generated are sufficient to effectively degrade TC-HCl (therefore, when Co / Fe-LDH is used to catalyze the degradation of tetracycline hydrochloride, its degradation efficiency is best in the PMS system with an initial pH of 5). However, when the environment is too acidic (pH = 3), excessive H + It will neutralize some active free radicals and reduce the degradation efficiency. When the pH value increases to alkaline (pH = 9 and 11), the degradation efficiency drops sharply because under alkaline conditions, the structural stability of Co / Fe-LDH and the activation of PMS are inhibited, resulting in a decrease in the number of effective free radicals. Therefore, pH = 7 was selected as the optimal condition for subsequent experiments.
[0081] At the same time, the stability of the optimal catalyst was investigated by cyclic tests using LEV, SMX, and TC-HCl degradation experiments. After each cycle, the catalyst was centrifuged and washed with deionized water. Figure 20-22 As shown in the figure, from the first cycle to the fifth cycle, the degradation rate of LEV and SMX by the catalyst decreased by 25% and 30%, respectively. During the catalytic process, pollutants and their degradation products formed complexes on the catalyst surface, hindering the availability of active sites. With the increase in the number of regeneration cycles, the removal rate decreased slightly, but satisfactory results were still obtained, indicating that the Co / Fe-LDH catalyst has good reusability and stability.
[0082] In order to further evaluate the catalytic degradation ability of Co / Fe-LDH, it was also used to simultaneously degrade multiple antibiotic pollutants. In a solution with an initial concentration of 30 mg / L of LEV, SMX and TC-HCl, the material and PMS dosage were 0.01 g, respectively. The results are as follows: Fig.23 As shown in the figure, Co / Fe-LDH has good degradation performance for LEV (85.40%), SMX (80.74%) and TC-HCl (97.08%). In summary, Co / Fe-LDH catalyst has broad application prospects in the field of water treatment due to its excellent catalytic performance, good stability and environmental friendliness.
[0083] The present invention adopts a coprecipitation method to prepare LDHs of different divalent metals and trivalent metals. The Co / Fe-LDH composite material prepared after optimization has a layered structure of LDH that provides a large number of active sites. The synergistic effect of Co and Fe in the LDH structure not only enhances the catalytic activity of LDH, but also may lead to the exposure of more active sites. These sites can effectively interact with PMS and promote the generation of effective free radicals, thereby having a high ability to degrade multiple antibiotics. In addition, the stability and reusability of the Co / Fe-LDH composite material also demonstrate its potential in practical applications, and has a high application and promotion value.
[0084] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A method for preparing LDHs, characterized in that: The steps include: S1. Mixing the divalent metal and the trivalent metal according to the metal molar ratio of 2:1-4:1, taking the same volume of the divalent metal solution and the trivalent metal solution to obtain a mixed solution; S2. NaOH solution was added dropwise to the mixed solution, and the pH value was adjusted to alkaline and then allowed to stand; S3. Filter and wash with deionized water, and then dry to obtain a layered double metal hydroxide material.
2. A method for preparing LDHs according to claim 1, characterized in that: In step S1, the divalent metal is Cu 2+ Mg 2+ or Co 2+ Any one of the above, the divalent metal solution is any one of Cu(NO3)2·3H2O, Mg(NO3)2·6H2O or Co(NO3)2·6H2O solution, and the layered double hydroxide materials prepared therefrom are Cu / Fe-LDH, Mg / Fe-LDH, and Co / Fe-LDH respectively.
3. A method for preparing LDHs according to claim 2, characterized in that: In step S1, the trivalent metal is Fe 3+ , the trivalent metal solution is Fe(NO3)3·9H2O solution.
4. A method for preparing LDHs according to claim 3, characterized in that: In step S1, 100 mL of divalent metal solution and 100 mL of trivalent metal solution are mixed at a metal molar ratio of 2:1-4:1 to obtain a mixed solution, wherein the total concentration of divalent metal and trivalent metal ions in the mixed solution is 0.5 mol / L.
5. The method for preparing LDHs according to claim 2, characterized in that: In step S1, the divalent metal is Co 2+ , the divalent metal solution is Co(NO3)2·6H2O solution.
6. The method for preparing LDHs according to any one of claims 2 to 5, characterized in that: In step S2, NaOH solution is added dropwise to the mixed solution, the pH value is adjusted to 13, and then the solution is allowed to stand at room temperature for 24 hours.
7. An application of LDHs in catalytic degradation of antibiotics, based on the preparation method of LDHs described in claims 2-6, characterized in that: The Cu / Fe-LDH, Mg / Fe-LDH and Co / Fe-LDH catalyze the degradation of levofloxacin, tetracycline hydrochloride and sulfamethoxazole in the PMS system.
8. The use of LDHs in catalytic degradation of antibiotics according to claim 7, characterized in that: Based on the condition that the initial mass concentration of levofloxacin, tetracycline hydrochloride and sulfamethoxazole is 30 mg / L, the dosage of the Co / Fe-LDH is 0.01 g, the dosage of the PMS is 0.01 g, and the initial pH value is 7, the levofloxacin, tetracycline hydrochloride and sulfamethoxazole are catalytically degraded.
9. The use of LDHs in catalytic degradation of antibiotics according to claim 7, characterized in that: The Co / Fe-LDH can be repeatedly used in the PMS system to catalyze the degradation of levofloxacin, tetracycline hydrochloride, and sulfamethizole, or can be simultaneously used to catalyze the degradation of levofloxacin, tetracycline hydrochloride, and sulfamethizole.
Citation Information
Patent Citations
Method for removing ofloxacin by activating persulfate through MnFe-LDH single sheet
CN114671509A
Preparation method of supported FeCo-LDH (layered double hydroxide) silicon dioxide heterogeneous persulfate activator as well as product and application of supported FeCo-LDH silicon dioxide heterogeneous persulfate activator
CN115487812A
G-C3N4 / FeCu-LDH composite material as well as preparation method and application thereof
CN116943705A
Preparation of MnFe-LDH / g-C3N4 composite catalyst for rapidly removing antibiotics in water
CN117358281A
Layered magnesium manganese composite material for copper ion adsorption, preparation method therefor and application thereof
US20220288567A1
